miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia

• Estrella Gonzales-Aloy,
• Patrick Connerty,
• Basit Salik,
• Bing Liu,
• Andrew J. Woo,
• Michelle Haber,
• Murray D. Norris,
• Jianlong Wang,
• Jenny Y. Wang

Affiliations

Estrella Gonzales-Aloy

Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia

Patrick Connerty

Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia

Basit Salik

Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia

Bing Liu

Kids Cancer Alliance, Translational Cancer Research Centre for Kids, Cancer Institute New South Wales, Sydney, Australia

Andrew J. Woo

Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, the University of Western Australia, Crawley, Australia;Centre for Medical Research, The University of Western Australia, Crawley, Australia

Michelle Haber

Children’s Cancer Institute, University of New South Wales, Sydney, Australia

Murray D. Norris

Children’s Cancer Institute, University of New South Wales, Sydney, Australia

Jianlong Wang

Department of Cell, Developmental and Regenerative Biology, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Jenny Y. Wang

Cancer and Stem Cell Biology Group, Children’s Cancer Institute, University of New South Wales, Sydney, Australia